Sheri McMahon - Concepedia

Author

Sheri McMahon

National Cancer Institute

Also Known As

S McMahon, S. G. McMahon, S. McMahon, Sheri McMahon, Stephanie McMahon

Publications

671

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute National Institutes of Health Center for Cancer Research Office of the Director Rutgers, The State University of New Jersey

About

Sheri McMahon is an author at National Cancer Institute specializing in medicine, immunotherapy, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	48
2	Health Sciences	2	2	33
3	Pharmacology	2	2	36
4	Cancer Therapeutics	2	2	33
5	Immunology	1	1	12

Sheri McMahon

Publications

591

Citations

H-Index

Page 1

	Year	Citations
First-in-Human Phase I Trial of a Tumor-Targeted Cytokine (NHS-IL12) in Subjects with Metastatic Solid Tumors Julius Strauss, Christopher R. Heery, Joseph W. Kim, Clinical Cancer Research	2018	164
Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer Christopher R. Heery, Nuhad K. Ibrahim, Philip M. Arlen, JAMA Oncology	2015	99
Phase I Study of a Poxviral TRICOM-Based Vaccine Directed Against the Transcription Factor Brachyury Christopher R. Heery, Claudia Palena, Sheri McMahon, Clinical Cancer Research	2017	65
A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)-Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer Margaret E. Gatti‐Mays, Jason M. Redman, Renee N. Donahue, The Oncologist	2019	59
Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC) Marijo Bilušić, Sheri McMahon, Ravi A. Madan, Journal for ImmunoTherapy of Cancer	2021	59
A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer Jason M. Redman, Yo-Ting Tsai, Benjamin A. Weinberg, The Oncologist	2022	48
A randomized phase II study of flutamide with or without PSA-TRICOM in nonmetastatic castration-resistant prostate cancer (CRPC). Marijo Bilušić, James L. Gulley, C. Heery, Journal of Clinical Oncology UrologyOncologyGenitourinary CancerMedian SurvivalMedicine	2011	21
Comparison of Nitrendipine Combined with Low-Dose Hydrochlorothiazide to Hydrochlorothiazide Alone in Mild to Moderate Essential Hypertension James A. Schoenberger, S. P. Glasser, C. Venkata S. Ram, Journal of Cardiovascular Pharmacology HypertensionCardiovascular DiseaseNitrendipine CombinedModerate Essential HypertensionMg B.i.d	1984	15
A Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors Margaret E. Gatti‐Mays, Nicholas Tschernia, Julius Strauss, The Oncologist	2023	14
Combining active immunotherapy and immune checkpoint inhibitors in prostate cancer. Harpreet Singh, Ravi A. Madan, William L. Dahut, Journal of Clinical Oncology Prostvac Active ImmunotherapyActive ImmunotherapyImmunologyImmunoeditingImmunotherapeutics	2015	12

Page 1